Sparrow Health System
Sparrow Health System Sparrow Health System
  Sparrow Search
  
Sparrow Health System
 Affiliates/Partners
Human Resources
News & Events
Patient/Visitor
Services Site Map Contact Us 
Sparrow Regional Cancer Center: Research & Clinical Trials

Home

What are clinical trials?
Brain Studies
Breast Studies
Gastro-Intestinal Studies
Hematological Studies
Lung Studies
Lymphoma Studies
Multiple Myeloma Studies
Pediatric & Adolescent Studies
Prevention Studies
Prostate Studies
Renal Cell Studies
Contact Us
Links

Other Resources:
  For Health Professionals
  Library
  SparrowHealth.net

Staff Photo

Lung Studies

Sparrow Regional Cancer Center - Clinical Trials

Quick Links:

NON-SMALL CELL LUNG CANCER (NSCLC)

A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) (ECOG E1505):

  • Patients must have undergone complete resection of their cancer prior to enrollment
  • Patients must be no less than 6 weeks and no more than 12 weeks post-thoracotomy and must be adequately recovered from surgery
  • Patients must not have received the following: Prior systemic chemotherapy at any time, Hormonal cancer therapy or radiation therapy prior cancer treatment
Sparrow Health System
Last modified on: 4/16/2008 2:09:31 PM
Sparrow Health System • Lansing, Michigan